The Guardian: U.K. refuses to back ‘game-changing’ resolution on drug pricing
“The U.K. government has refused to sign up to a global resolution on greater transparency for drug pricing. The resolution urges governments and others buying health products to share information on actual prices paid, and pushes for greater transparency on patents, clinical trial results, and other factors affecting pricing from laboratories to patients. … [T]he U.K., Germany, and Hungary have disassociated themselves from the resolution, which had already been watered down…” (Lamble, 5/28).